Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

ALK

ALK (anaplastic lymphoma kinase) is a member of insulin receptor protein-tyrosine superfamily, functioning in embryonic development and involved in cell survival and cell fate.

Items 1-10 of 21

Page
per page
  1. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  2. ALK inhibitor 2
    A3155 ALK inhibitor 2
    Summary: ALK inhibitor, novel and selective
      Soluble in DMSO
  3. ASP3026
    A3193 ASP3026
    Summary: ALK inhibitor,potent and selective
      insoluble in H2O; ≥14.53 mg/mL
  4. LDK378 dihydrochloride
    A3544 LDK378 dihydrochloride
    Summary: ALK inhibitor
  5. LDN193189 Hydrochloride
    A3545 LDN193189 Hydrochloride
     1 Citation
    Summary: ALK inhibitor,potent and selective
      ≥27.6 mg/mL
  6. TAE684 (NVP-TAE684)
    A8251 TAE684 (NVP-TAE684)
    Summary: ALK inhibitor,potent and selective
      ≥61.4 mg/mL
  7. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  8. ALK-IN-1
    A1367 ALK-IN-1
    Summary: Anaplastic lymphoma kinase (ALK) inhibitor
      ≥26.45 mg/mL
  9. LDN-193189
    A8324 LDN-193189
    Target: BMP and Other Activin Receptors
    Summary: ALK inhibitor,potent and selective
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  10. LDK378
    A8328 LDK378
    Target: ALK
    Summary: Potent ALK inhibitor
      insoluble in H2O; ≥13.95 mg/mL

Items 1-10 of 21

Page
per page